MACROGENICS, INC. Operating Leases, Future Minimum Payments, Due in Four Years
MACROGENICS, INC. (MGNX) had Operating Leases, Future Minimum Payments, Due in Four Years of $4.87 million as of 2018-12-31, per its 10-K filed 2019-02-26.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2019-02-26
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $4.87M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $4.74M.
- 2017-09-30: Operating Leases, Future Minimum Payments, Due in Four Years $4.78M.
- 2017-06-30: Operating Leases, Future Minimum Payments, Due in Four Years $3.45M.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years | Operating Leases, Future Minimum Payments, Due in Four Years as first filed |
|---|---|---|
| 2018-12-31 | $4.87M 10-K · filed 2019-02-26 | |
| 2017-12-31 | $4.74M 10-K · filed 2018-02-27 | |
| 2017-09-30 | $4.78M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $3.45M 10-Q · filed 2017-08-02 | |
| 2016-12-31 | $2.14M 10-K · filed 2017-02-28 | |
| 2015-12-31 | $3.80M 10-K · filed 2016-02-29 | |
| 2015-09-30 | $4.21M 10-Q · filed 2015-11-04 | |
| 2014-12-31 | $4.40M 10-K · filed 2015-03-03 | |
| 2014-09-30 | $4.29M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $4.29M 10-Q · filed 2014-08-05 | |
| 2013-12-31 | $4.29M 10-Q · filed 2014-05-06 | $3.51M 10-K · filed 2014-03-20 |
| 2013-09-30 | $3.49M 10-Q · filed 2013-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |